Genetic Signatures

35 for the financial year ended 30 June 2021 DIRECTORS’ REPORT FOR THE FINANCIAL YEAR ENDED 30 JUNE 2021 13 John Melki Director & Chief Executive Officer Contract term: Ongoing, commenced November 2014 Base salary: $360,000, exclusive of superannuation, to be reviewed annually by the Remuneration Committee. Termination payments: Payment on early termination by the Group, other than for gross misconduct, equal to the base salary plus superannuation entitlements for three months. Michael Aicher Executive Director – US Operations Contract term: Ongoing, commenced April 2014 Base salary: $US120,000, to be reviewed annually by the Remuneration Committee. Termination payments: No payment on early termination. Contract is terminable by either party on one months’ notice. Peter Manley Chief Financial Officer Contract term: Ongoing, commenced October 2018 Base salary: $232,635 exclusive of superannuation, to be reviewed annually by the Remuneration Committee. Termination payments: Payment on early termination by the Group, other than for gross misconduct, equal to the base salary plus superannuation for three months. This concludes the remuneration report which has been audited. OPTIONS There were 4,360,000 unissued ordinary shares of the company under option outstanding at the date of this report. During the financial year 1,715,000 new options were issued, 296,250 were exercised, and 337,500 were forfeited. INDEMNIFICATION OF OFFICERS AND AUDITORS Genetic Signatures Ltd paid an insurance premium during the financial year, for Directors’ & Officers Liability insurance cover. No person has applied for leave of court to bring proceedings on behalf of the company or intervene in any proceedings to which the company is a party for the purpose of taking responsibility on behalf of the company for all or any part if those proceedings. The company’s operations are not regulated by any significant environmental regulation under a law of the Commonwealth or of a state or territory. PROCEEDINGS ON BEHALF OF THE COMPANY No person has applied to the Court under section 237 of the Corporations Act 2001 for leave to bring proceedings on behalf of the company, or to intervene in any proceedings to which the company is a party for the purpose of taking responsibility on behalf of the company for all or part of those proceedings.